Home/Filings/4/0001493152-21-029395
4//SEC Filing

Beyer Russell P 4

Accession 0001493152-21-029395

CIK 0001833214other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:45 PM ET

Size

5.7 KB

Accession

0001493152-21-029395

Insider Transaction Report

Form 4
Period: 2021-11-17
Beyer Russell P
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-11-17+110,000110,000 total
    Exercise: $11.17Exp: 2031-11-17Common Stock (110,000 underlying)
Footnotes (2)
  • [F1]Represents options to purchase shares of common stock granted to the Reporting Person pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
  • [F2]The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.

Documents

1 file

Issuer

SAB Biotherapeutics, Inc.

CIK 0001833214

Entity typeother

Related Parties

1
  • filerCIK 0001889754

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:45 PM ET
Size
5.7 KB